192 results
Page 4 of 10
8-K
EX-5.1
l85y6i4gz
4 Apr 23
Checkpoint Therapeutics Announces $6.1 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
6:05am
8-K
EX-4.1
uqlxr5
4 Apr 23
Checkpoint Therapeutics Announces $6.1 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
6:05am
424B5
7k2segi
4 Apr 23
Prospectus supplement for primary offering
6:03am
8-K
EX-99.1
e1zgh4mw
31 Mar 23
Checkpoint Therapeutics Reports Full-Year 2022 Financial Results and Recent Corporate Highlights
6:00am
8-K
EX-5.1
zlhdgcd2i3hijf
16 Dec 22
Checkpoint Therapeutics Announces $7.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
7:05am
8-K
EX-10.1
vwepsbe
16 Dec 22
Checkpoint Therapeutics Announces $7.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
7:05am
8-K
EX-4.2
e3bk1j
16 Dec 22
Checkpoint Therapeutics Announces $7.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
7:05am
8-K
EX-4.3
atpvf9e4gu ph
16 Dec 22
Checkpoint Therapeutics Announces $7.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
7:05am
8-K
EX-4.1
dh5rn7nj
16 Dec 22
Checkpoint Therapeutics Announces $7.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
7:05am
424B5
4swqw
16 Dec 22
Prospectus supplement for primary offering
7:00am
S-8
t48bm98dy
9 Dec 22
Registration of securities for employees
5:01pm
S-8
EX-5.1
lekb7h0l 2irf1e1rw
9 Dec 22
Registration of securities for employees
5:01pm
S-8
EX-23.1
zx8d91a00om 76o3hf8
9 Dec 22
Registration of securities for employees
5:01pm
DEF 14C
mfmu9t1
14 Nov 22
Information statement
5:00pm
PRE 14C
wyd6m
4 Nov 22
Preliminary information
5:22pm